BIOQUAL, Inc.
BIOQ
$38.51
-$1.49-3.73%
OTC PK
| 08/31/2025 | 05/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -15.54% | -16.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -15.54% | -16.85% | |||
| Cost of Revenue | 60.71% | -50.55% | |||
| Gross Profit | -85.60% | 122.54% | |||
| SG&A Expenses | -77.51% | 297.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.99% | -8.34% | |||
| Operating Income | -338.92% | -110.07% | |||
| Income Before Tax | -1,405.70% | -97.96% | |||
| Income Tax Expenses | -176.91% | -65.38% | |||
| Earnings from Continuing Operations | -157.29% | -110.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -157.29% | -110.33% | |||
| EBIT | -338.92% | -110.07% | |||
| EBITDA | -89.39% | -74.67% | |||
| EPS Basic | -157.35% | -110.33% | |||
| Normalized Basic EPS | -1,404.35% | -97.96% | |||
| EPS Diluted | -154.55% | -110.51% | |||
| Normalized Diluted EPS | -1,404.35% | -97.96% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||